These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8830849)
41. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease. Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148 [TBL] [Abstract][Full Text] [Related]
42. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys. Oiwa Y; Nakai K; Itakura T Neurol Med Chir (Tokyo); 2006 Jun; 46(6):267-75; discussion 275-6. PubMed ID: 16794346 [TBL] [Abstract][Full Text] [Related]
43. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. Slevin JT; Gerhardt GA; Smith CD; Gash DM; Kryscio R; Young B J Neurosurg; 2005 Feb; 102(2):216-22. PubMed ID: 15739547 [TBL] [Abstract][Full Text] [Related]
44. Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones. Bauer M; Suppmann S; Meyer M; Hesslinger C; Gasser T; Widmer HR; Ueffing M J Neurochem; 2002 Sep; 82(5):1300-10. PubMed ID: 12358777 [TBL] [Abstract][Full Text] [Related]
45. Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury. Cheng H; Wu JP; Tzeng SF J Neurosci Res; 2002 Aug; 69(3):397-405. PubMed ID: 12125080 [TBL] [Abstract][Full Text] [Related]
46. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related]
47. GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Yang F; Feng L; Zheng F; Johnson SW; Du J; Shen L; Wu CP; Lu B Nat Neurosci; 2001 Nov; 4(11):1071-8. PubMed ID: 11593232 [TBL] [Abstract][Full Text] [Related]
48. Interactions of neurotrophic factors GDNF and NT-3, but not BDNF, with the immune system following fetal spinal cord transplantation. Shinoda M; Hoffer BJ; Olson L Brain Res; 1996 May; 722(1-2):153-67. PubMed ID: 8813361 [TBL] [Abstract][Full Text] [Related]
49. Effects of age and GDNF on noradrenergic innervation of the hippocampal formation: studies from intraocular grafts. Granholm AC; Helt C; Srivastava N; Backman C; Gerhardt GA Microsc Res Tech; 2001 Sep; 54(5):298-308. PubMed ID: 11514986 [TBL] [Abstract][Full Text] [Related]
50. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Kordower JH; Emborg ME; Bloch J; Ma SY; Chu Y; Leventhal L; McBride J; Chen EY; Palfi S; Roitberg BZ; Brown WD; Holden JE; Pyzalski R; Taylor MD; Carvey P; Ling Z; Trono D; Hantraye P; Déglon N; Aebischer P Science; 2000 Oct; 290(5492):767-73. PubMed ID: 11052933 [TBL] [Abstract][Full Text] [Related]
52. Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. Hebert MA; Van Horne CG; Hoffer BJ; Gerhardt GA J Pharmacol Exp Ther; 1996 Dec; 279(3):1181-90. PubMed ID: 8968339 [TBL] [Abstract][Full Text] [Related]
53. Protective effect of liposome-mediated glial cell line-derived neurotrophic factor gene transfer in vivo on motoneurons following spinal cord injury in rats. Lu KW; Chen ZY; Hou TS Chin J Traumatol; 2004 Oct; 7(5):275-9. PubMed ID: 15363220 [TBL] [Abstract][Full Text] [Related]
54. Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease. Lapchak PA; Miller PJ; Jiao S; Araujo DM; Hilt D; Collins F Neurodegeneration; 1996 Sep; 5(3):197-205. PubMed ID: 8910897 [No Abstract] [Full Text] [Related]
55. Dihydroergocryptine improves behavioral deficits of aged male rats. Drago F; Valerio C; D'Agata V; Lauria N; Scapagnini U Neurobiol Aging; 1988; 9(3):285-90. PubMed ID: 3135503 [TBL] [Abstract][Full Text] [Related]
56. Reduction of motor behavioral deficits in senescent animals via chronic prolactin administration. II. Non-stereotypic behaviors. Joseph JA; Lippa AS Neurobiol Aging; 1986; 7(1):37-40. PubMed ID: 3951657 [TBL] [Abstract][Full Text] [Related]
57. A new motor test sensitive to aging and dopaminergic function. Drucker-Colín R; García-Hernández F J Neurosci Methods; 1991 Sep; 39(2):153-61. PubMed ID: 1798345 [TBL] [Abstract][Full Text] [Related]
58. Upregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult Brain. Moon GJ; Shin M; Kim SR Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188096 [TBL] [Abstract][Full Text] [Related]